FDA's requirements for clinical pharmacology section of prescription drug labeling / 药物评价研究
Drug Evaluation Research
;
(6): 442-449, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-619579
ABSTRACT
FDA issued the Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry (final guidance)in December 2016.The Guidance stipulated that clinical pharmacology section must contain three subsections—echanism of action,pharmacodynamics,and pharmacokinetics;If necessary,it can be added to microbiology and pharmacogenomics subsections etc.,as well as explained that the contents of each subsection should be included,also discussed the writing general principles and the format of the section.This paper introduces the main contents of the guidance,with the hope of helping writing and supervision on our country labeling.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
Drug Evaluation Research
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS